| CEO Name | Bruce Cozadd |
| Nationality | United States |
| Net Worth Estimation | $150 million |
Bruce Cozadd's estimated net worth of around $150 million primarily stems from his long-term equity holdings, executive compensation, and stock options as CEO and co-founder of Jazz Pharmaceuticals plc. His wealth is closely tied to the company's financial performance and sustained stock appreciation over his tenure.
Bruce Cozadd's estimated net worth of $150,000,000 is 67% higher than the maximum typical CEO net worth of $90,000,000 in the healthcare sector. His net worth is also 15 times greater than the minimum benchmark of $10,000,000 for CEOs in this category.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Bruce Cozadd Performance in Jazz Pharmaceuticals plc
Bruce Cozadd, CEO of Jazz Pharmaceuticals plc, demonstrates strong leadership by driving innovation and strategic growth in biopharma. His decisive focus on portfolio expansion and operational efficiency has significantly boosted Jazz's market presence and financial performance. Under his guidance, the company has accelerated drug development and global commercialization, solidifying its industry position.
Latest News
Jazz Pharmaceuticals Appoints Renee Gala as New CEO Amid Strong Financial Growth
Renee Gala will become President and CEO of Jazz Pharmaceuticals on August 11, 2025, succeeding Bruce Cozadd who is retiring but will remain as Chairperson. The company reported $1.05 billion in Q2 2025 revenues, with robust growth in its sleep and oncology portfolios.
Source: http://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-second-quarter-2025-financial-results-and-updates-2025-financial-guidance-302522282.html